ArticleMolecular carcinogenesis2019

Inhibition of mutant Kras and p53-driven pancreatic carcinogenesis by atorvastatin: Mainly via targeting of the farnesylated DNAJA1 in chaperoning mutant p53.

Dandan Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.